Has Dora Leung, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,110 in general payments to Dora Leung, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dora Leung, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dora Leung, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dora Leung, MD

Neurology · New York, NYNPI 1659424596

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AstraZeneca at 45.2% of the total. 2025 is the largest year on record at $600, 5.1 times the $118 reported in 2022. That places this record below the midpoint for neurology clinicians in NY, where the typical reported total is $913.

$1,110in general payments, 2019–2025

Across 15 payments — averaging $73.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$502
Argenx US, Inc.$277
Amneal Pharmaceuticals LLC$125
Tanabe Pharma America, Inc.$84
Biogen$61
Takeda Pharmaceuticals U.S.A., Inc.$35
plus $26 from 1 others

$22,999in research payments, 2019–2025

Across 2 payments — averaging $11,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

UCB SA$23K

What the payments were for

Food & beverage$1,08197%
Education$283%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	4	$502
Argenx US, Inc.	3	$277
Amneal Pharmaceuticals LLC	1	$125
Tanabe Pharma America, Inc.	3	$84
Biogen	2	$61
Takeda Pharmaceuticals U.S.A., Inc.	1	$35
Genentech USA, Inc.	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,110 in reported general payments places this provider in the 50th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$236,811

Medicare patients

431

Services billed

3,961

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
GammakedImmune Globul G/Gly/Iga Avg 46	15	$752,888
PanzygaImmun Glob G(Igg)-Ifas/Glycine	20	$429,284
GammaplexImmun Glob G(Igg)/Gly/Iga 0-50	38	$409,152
Gamunex-CImmune Globul G/Gly/Iga Avg 46	81	$379,902
HizentraImmun Glob G(Igg)/Pro/Iga 0-50	33	$284,043
Radicava OrsEdaravone	19	$266,020
TeglutikRiluzole	11	$41,735
NuedextaDextromethorphan Hbr/Quinidine	12	$21,498
Riluzole	36	$8,897
Gabapentin	410	$7,744
Pregabalin	47	$1,413
Duloxetine Hcl	47	$1,321
Baclofen	32	$367
Eszopiclone	11	$269
Methylprednisolone Sodium SuccMethylprednisolone Sod Succ	13	$268

Paid to pharmacies, not to this prescriber.

Other neurology in New York

Stephen KriegerNew York$1.1M
Sheng-Han KuoNew York$657K
Timothy VartanianNew York$468K
Steven WolfNew York$428K
David DodickNew York$426K
David SimpsonNew York$403K
Fred LublinNew York$383K
Alexander ShtilbansNew York$374K
Andrew LassmanNew York$359K
Brian ApatoffNew York$295K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →